Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 Laser Assisted PDT for BCC and AK
NCT01260987Phase 3Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Oct 2010
- Primary completion
- Aug 2012
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of methyl aminolevulinate in actinic keratosis (AK), basal cell carcinoma (BCC), sponsored by Bispebjerg and Frederiksberg Hospital. Started Oct 2010; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT01260987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01260987.